Michelle Dawson, BSc (Pharm), PhD
Senior Director, Product Development Consulting
Michelle Dawson is a Senior Director in the Product Development Consulting team at Fortrea, based in the UK, with nearly 30 years of experience in pharmaceutical research and development. She has a strong track record in leading drug product development from early clinical phases through launch and post-approval lifecycle management.
Michelle began her career at Novartis Horsham Research Centre, working on dry powder inhaler development, and later spent over 20 years at GlaxoSmithKline research and development as a matrix leader in formulation development, primarily in respiratory medicine. She played a key role in the regulatory approval of multiple Ellipta® dry powder inhalers and later supported post-approval and lifecycle activities in Global Regulatory Affairs. Prior to joining Fortrea in 2022, she served as Director of Formulation Development at Pharmaron UK.
Michelle is a qualified pharmacist, holding a degree from the University of Manchester and a PhD in Pharmaceutics from Cardiff University.